An inducible RIPK3-driven necroptotic system enhances cancer cell–based immunotherapy and ensures safety
Kok‐Siong Chen(Brigham and Women's Hospital), Khalid Shah(Brigham and Women's Hospital)
Cited by 11
Related Papers
Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types
|Nature Communications|2020|159
Engineered cell-based therapies in ex vivo ready-made CellDex capsules have therapeutic efficacy in solid tumors
|Biomedicine & Pharmacotherapy|2023|16
IL13Rα2‑ and EGFR‑targeted pseudomonas exotoxin potentiates the TRAIL‑mediated death of GBM cells
|International Journal of Molecular Medicine|2021|11